Capital India Finance Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 5, 2025, 5:06 am

Competitors of Capital India Finance Ltd

All Competitor Stocks of Capital India Finance Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:36 am

Below is a detailed analysis of the quarterly data for Capital India Finance Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 139.33 Cr.. The value appears to be declining and may need further review. It has decreased from 152.93 Cr. (Dec 2024) to 139.33 Cr., marking a decrease of 13.60 Cr..
• For Expenses, as of Mar 2025, the value is 108.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 118.40 Cr. (Dec 2024) to 108.43 Cr., marking a decrease of 9.97 Cr..
• For Operating Profit, as of Mar 2025, the value is 30.90 Cr.. The value appears to be declining and may need further review. It has decreased from 34.53 Cr. (Dec 2024) to 30.90 Cr., marking a decrease of 3.63 Cr..
• For OPM %, as of Mar 2025, the value is 22.18%. The value appears to be declining and may need further review. It has decreased from 22.58% (Dec 2024) to 22.18%, marking a decrease of 0.40%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.44 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.56 Cr..
• For Interest, as of Mar 2025, the value is 27.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.74 Cr. (Dec 2024) to 27.88 Cr., marking an increase of 0.14 Cr..
• For Depreciation, as of Mar 2025, the value is 7.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.15 Cr. (Dec 2024) to 7.94 Cr., marking a decrease of 0.21 Cr..
• For Profit before tax, as of Mar 2025, the value is -2.92 Cr.. The value appears to be declining and may need further review. It has decreased from -0.92 Cr. (Dec 2024) to -2.92 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Mar 2025, the value is -11.99%. The value appears to be improving (decreasing) as expected. It has decreased from 107.61% (Dec 2024) to -11.99%, marking a decrease of 119.60%.
• For Net Profit, as of Mar 2025, the value is -2.56 Cr.. The value appears to be declining and may need further review. It has decreased from -1.91 Cr. (Dec 2024) to -2.56 Cr., marking a decrease of 0.65 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.02. The value appears to be declining and may need further review. It has decreased from 0.02 (Dec 2024) to -0.02, marking a decrease of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:42 am

Growth

Last Updated: September 5, 2025, 2:46 pm

Balance Sheet

Last Updated: December 4, 2025, 2:35 am

Below is a detailed analysis of the balance sheet data for Capital India Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 78.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 78.00 Cr..
• For Reserves, as of Sep 2025, the value is 594.00 Cr.. The value appears strong and on an upward trend. It has increased from 550.00 Cr. (Mar 2025) to 594.00 Cr., marking an increase of 44.00 Cr..
• For Borrowings, as of Sep 2025, the value is 700.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 996.00 Cr. (Mar 2025) to 700.00 Cr., marking a decrease of 296.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 229.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 228.00 Cr. (Mar 2025) to 229.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,601.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,853.00 Cr. (Mar 2025) to 1,601.00 Cr., marking a decrease of 252.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 7.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Sep 2025, the value is 197.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 197.00 Cr., marking an increase of 133.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,321.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,691.00 Cr. (Mar 2025) to 1,321.00 Cr., marking a decrease of 370.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,601.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,853.00 Cr. (Mar 2025) to 1,601.00 Cr., marking a decrease of 252.00 Cr..

However, the Borrowings (700.00 Cr.) are higher than the Reserves (594.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Capital India Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 2.00, marking a decrease of 8.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 1.50 (Mar 24) to 0.04, marking a decrease of 1.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 1.48 (Mar 24) to 0.04, marking a decrease of 1.44.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 3. It has decreased from 3.05 (Mar 24) to 0.55, marking a decrease of 2.50.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.14. It has decreased from 80.10 (Mar 24) to 16.14, marking a decrease of 63.96.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.14. It has decreased from 80.10 (Mar 24) to 16.14, marking a decrease of 63.96.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 15.79. It has decreased from 87.49 (Mar 24) to 15.79, marking a decrease of 71.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.33. This value is within the healthy range. It has decreased from 15.85 (Mar 24) to 3.33, marking a decrease of 12.52.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.51. This value is within the healthy range. It has decreased from 11.97 (Mar 24) to 2.51, marking a decrease of 9.46.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.22. This value is below the healthy minimum of 0. It has decreased from 0.16 (Mar 24) to -0.22, marking a decrease of 0.38.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.26. This value is below the healthy minimum of 2. It has increased from -0.82 (Mar 24) to -0.26, marking an increase of 0.56.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 1.50 (Mar 24) to 0.03, marking a decrease of 1.47.
• For PBDIT Margin (%), as of Mar 25, the value is 21.11. This value is within the healthy range. It has increased from 18.11 (Mar 24) to 21.11, marking an increase of 3.00.
• For PBIT Margin (%), as of Mar 25, the value is 15.91. This value is within the healthy range. It has increased from 13.67 (Mar 24) to 15.91, marking an increase of 2.24.
• For PBT Margin (%), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 10. It has decreased from 0.19 (Mar 24) to -1.44, marking a decrease of 1.63.
• For Net Profit Margin (%), as of Mar 25, the value is -1.66. This value is below the healthy minimum of 5. It has decreased from -0.94 (Mar 24) to -1.66, marking a decrease of 0.72.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 8. It has decreased from 1.71 (Mar 24) to 0.25, marking a decrease of 1.46.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 15. It has decreased from 1.87 (Mar 24) to 0.24, marking a decrease of 1.63.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.47. This value is within the healthy range. It has increased from 13.54 (Mar 24) to 14.47, marking an increase of 0.93.
• For Return On Assets (%), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 24) to 0.08, marking a decrease of 0.56.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.55. This value exceeds the healthy maximum of 1. It has increased from 1.42 (Mar 24) to 1.55, marking an increase of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.37 (Mar 24) to 0.33, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 1.5. It has decreased from 1.49 (Mar 24) to 1.46, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 1.49 (Mar 24) to 1.46, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 590.24. This value exceeds the healthy maximum of 8. It has increased from 1.46 (Mar 24) to 590.24, marking an increase of 588.78.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 50.22. This value exceeds the healthy maximum of 50. It has increased from 6.67 (Mar 24) to 50.22, marking an increase of 43.55.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 20. It has increased from 1.85 (Mar 24) to 2.32, marking an increase of 0.47.
• For Earning Retention Ratio (%), as of Mar 25, the value is 49.78. This value is within the healthy range. It has decreased from 93.33 (Mar 24) to 49.78, marking a decrease of 43.55.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.68. This value exceeds the healthy maximum of 70. It has decreased from 98.15 (Mar 24) to 97.68, marking a decrease of 0.47.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 3. It has increased from 1.21 (Mar 24) to 1.22, marking an increase of 0.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 3. It has increased from 0.83 (Mar 24) to 0.90, marking an increase of 0.07.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,911.81. It has increased from 1,607.41 (Mar 24) to 1,911.81, marking an increase of 304.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.11. This value exceeds the healthy maximum of 3. It has increased from 2.36 (Mar 24) to 3.11, marking an increase of 0.75.
• For EV / EBITDA (X), as of Mar 25, the value is 14.73. This value is within the healthy range. It has increased from 13.05 (Mar 24) to 14.73, marking an increase of 1.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.93, marking an increase of 0.42.
• For Retention Ratios (%), as of Mar 25, the value is 49.77. This value is within the healthy range. It has decreased from 93.32 (Mar 24) to 49.77, marking a decrease of 43.55.
• For Price / BV (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 1.89, marking an increase of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.93, marking an increase of 0.42.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness